<DOC>
	<DOCNO>NCT00836953</DOCNO>
	<brief_summary>To describe safety finding Days 0 44 follow injection 2003-2004 pediatric formulation inactivate , split-virion influenza vaccine Fluzone® , give two-dose schedule accordance Package Insert , child age ≥ 6 month &lt; 36 month . To describe immunogenicity finding Days 0 44 follow injection 2003-2004 pediatric formulation inactivate , split-virion influenza vaccine Fluzone® , give two-dose schedule accordance Package Insert , child age ≥ 6 month &lt; 36 month</brief_summary>
	<brief_title>Study Collect Sera Immunogenicity Testing Children Vaccinated With Fluzone®</brief_title>
	<detailed_description>The study collect serum healthy child administer 2003-2004 formulation inactivate , split-virion influenza vaccine Fluzone® .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Aged ≥ 6 month &lt; 36 month . Considered good health basis report medical history limited physical examination . Available duration study ( 44 day +4 day ) . Parent/guardian willing able provide inform consent . Parent/guardian willing able meet protocol requirement . Exclusion Criteria : Reported allergy egg protein , chicken protein , constituent vaccine . Previous history influenza vaccination document history influenza infection . An acute illness without fever ( temperature &gt; 100.4 °F rectal ) 72 hour precede enrollment trial ( defer enrollment ) . Clinically significant finding vital sign review system ( investigator judgment ; defer exclude ) . Participation clinical trial within 30 day prior enrollment termination subject 's participation study . Known suspect impairment immunologic function , receipt immunosuppressive therapy immunoglobulin since birth . Personal immediate family history congenital immune deficiency . Developmental delay , neurologic disorder , seizure disorder . Chronic medical , congenital , developmental disorder . Known human immunodeficiency virus ( HIV ) positive mother . Prior history GuillainBarré syndrome . Any condition , opinion investigator , would pose health risk subject interfere evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Fluzone®</keyword>
	<keyword>Children</keyword>
</DOC>